Search research articles
Contact Us
Filters
Showing results (71-80 of 184) with videos related to
Page
of 19
Sort By:
Open Research Europe
|
June 20, 2024
Deriving lessons learned from monitoring adaptation activities in projects under the EU mission on adaptation
Stephanie Bilgram, Carla Klusmann, Christian Kind, et al.
Blood
|
April 21, 2012
Rearrangement of NOTCH1 or BCL3 can independently trigger progression of CLL
Kim De Keersmaecker, Lucienne Michaux, André Bosly, et al.
Hemasphere
|
November 15, 2019
<i>BCR-ABL1</i> positive B-ALL can undergo T-cell lineage shift to become CD19 negative T-ALL
Jolien De Bie, Sofie Demeyer, Olga Gielen, et al.
Blood
|
November 25, 2003
The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia
Jan Cools, Hilmar Quentmeier, Brian J P Huntly, et al.
Cancer Research
|
September 18, 2004
Prediction of resistance to small molecule FLT3 inhibitors: implications for molecularly targeted therapy of acute leukemia
Jan Cools, Nicole Mentens, Pascal Furet, et al.
Water Research
|
July 10, 2024
Framework for mapping large-scale nature-based solutions for drought mitigation: Regional application in Flanders
Estifanos Addisu Yimer, Lien De Trift, Stefaan Dondeyne, et al.
Hemasphere
|
January 25, 2020
Ruxolitinib Synergizes With Dexamethasone for the Treatment of T-cell Acute Lymphoblastic Leukemia
Delphine Verbeke, Olga Gielen, Kris Jacobs, et al.
Blood
|
July 17, 2004
Variable sensitivity of FLT3 activation loop mutations to the small molecule tyrosine kinase inhibitor MLN518
Jennifer J Clark, Jan Cools, David P Curley, et al.
European Journal of Immunology
|
July 20, 2018
Malt1 self-cleavage is critical for regulatory T cell homeostasis and anti-tumor immunity in mice
Mathijs Baens, Rocco Stirparo, Youlia Lampi, et al.
European Journal of Medicinal Chemistry
|
April 10, 2013
Identification of novel FLT3 kinase inhibitors
Daphnie Pauwels, Hugo Klaassen, Idoya Lahortiga, et al.
Page
of 19
Search research articles
Search
Showing results (71-80 of 184) with videos related to
Sort By:
Page
of 19
Open Research Europe
|
June 20, 2024
Deriving lessons learned from monitoring adaptation activities in projects under the EU mission on adaptation
Stephanie Bilgram, Carla Klusmann, Christian Kind, et al.
Blood
|
April 21, 2012
Rearrangement of NOTCH1 or BCL3 can independently trigger progression of CLL
Kim De Keersmaecker, Lucienne Michaux, André Bosly, et al.
Hemasphere
|
November 15, 2019
<i>BCR-ABL1</i> positive B-ALL can undergo T-cell lineage shift to become CD19 negative T-ALL
Jolien De Bie, Sofie Demeyer, Olga Gielen, et al.
Blood
|
November 25, 2003
The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia
Jan Cools, Hilmar Quentmeier, Brian J P Huntly, et al.
Cancer Research
|
September 18, 2004
Prediction of resistance to small molecule FLT3 inhibitors: implications for molecularly targeted therapy of acute leukemia
Jan Cools, Nicole Mentens, Pascal Furet, et al.
Water Research
|
July 10, 2024
Framework for mapping large-scale nature-based solutions for drought mitigation: Regional application in Flanders
Estifanos Addisu Yimer, Lien De Trift, Stefaan Dondeyne, et al.
Hemasphere
|
January 25, 2020
Ruxolitinib Synergizes With Dexamethasone for the Treatment of T-cell Acute Lymphoblastic Leukemia
Delphine Verbeke, Olga Gielen, Kris Jacobs, et al.
Blood
|
July 17, 2004
Variable sensitivity of FLT3 activation loop mutations to the small molecule tyrosine kinase inhibitor MLN518
Jennifer J Clark, Jan Cools, David P Curley, et al.
European Journal of Immunology
|
July 20, 2018
Malt1 self-cleavage is critical for regulatory T cell homeostasis and anti-tumor immunity in mice
Mathijs Baens, Rocco Stirparo, Youlia Lampi, et al.
European Journal of Medicinal Chemistry
|
April 10, 2013
Identification of novel FLT3 kinase inhibitors
Daphnie Pauwels, Hugo Klaassen, Idoya Lahortiga, et al.
Page
of 19